MGC Pharmaceuticals Limited higher as it receives approval for Phase III trial of
The company said the trial will evaluate the efficacy and safety of CimetrA in the treatment of moderate hospitalised…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.